Castleark Management LLC Eli Lilly & CO Transaction History

Castleark Management LLC

$2.41 Billion
Q3 2024

A detailed history of Castleark Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Castleark Management LLC holds 65,326 shares of LLY stock, worth $50.2 Million. This represents 2.4% of its overall portfolio holdings.

Number of Shares

65,326

Previous 78,732 17.03%

Holding current value

$50.2 Million

Previous $71.3 Million 18.81%

% of portfolio

2.4%

Previous 2.95%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $10.4 Million - $12.9 Million	-13,406 Reduced 17.03%	65,326 $57.9 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $739,367 - $927,220	1,020 Added 1.31%	78,732 $71.3 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $609,966 - $816,048	-1,030 Reduced 1.31%	77,712 $60.5 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.23 Million - $1.45 Million	-2,343 Reduced 2.89%	78,742 $45.9 Million
Q3 2023 Nov 15, 2023	SELL	$434.7 - $599.3 $18.2 Million - $25 Million	-41,780 Reduced 34.0%	81,085 $43.6 Million
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $101,714 - $136,004	290 Added 0.24%	122,865 $57.6 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $590,197 - $693,158	-1,900 Reduced 1.53%	122,575 $42.1 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $6.77 Million - $7.89 Million	-21,050 Reduced 14.46%	124,475 $45.5 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $3.39 Million - $3.86 Million	-11,420 Reduced 7.28%	145,525 $47.1 Million
Q2 2022 Aug 16, 2022	SELL	$278.73 - $327.27 $2.69 Million - $3.16 Million	-9,650 Reduced 5.79%	156,945 $50.9 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $2.08 Million - $2.59 Million	-8,870 Reduced 5.06%	166,595 $47.7 Million
Q4 2021 Feb 16, 2022	SELL	$224.85 - $279.04 $85,443 - $106,035	-380 Reduced 0.22%	175,465 $48.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.43 Million - $1.76 Million	-6,445 Reduced 3.54%	175,845 $40.6 Million
Q2 2021 Aug 17, 2021	BUY	$180.55 - $233.54 $9.95 Million - $12.9 Million	55,120 Added 43.34%	182,290 $41.8 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $1.31 Million - $1.69 Million	7,945 Added 6.66%	127,170 $23.8 Million
Q4 2020 Feb 17, 2021	BUY	$130.46 - $172.63 $4.48 Million - $5.93 Million	34,365 Added 40.5%	119,225 $20.1 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $12.4 Million - $14.4 Million	84,860 New	84,860 $12.6 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $17.9 Million - $20.9 Million	-161,966 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $23.8 Million - $28 Million	-213,886 Reduced 56.91%	161,966 $21 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $9.13 Million - $10.2 Million	86,198 Added 29.76%	375,852 $43.5 Million
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $24.9 Million - $31.1 Million	289,654 New	289,654 $31.1 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Account

Castleark Management LLC Eli Lilly & CO Transaction History